IRIS
CASSANO, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.052
NA - Nord America 2.958
AS - Asia 1.790
SA - Sud America 58
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 6
Totale 7.872
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.936
IE - Irlanda 934
CN - Cina 874
UA - Ucraina 630
SE - Svezia 432
SG - Singapore 347
IT - Italia 306
HK - Hong Kong 185
DE - Germania 178
RU - Federazione Russa 162
FR - Francia 154
IN - India 142
FI - Finlandia 120
TR - Turchia 105
KR - Corea 77
GB - Regno Unito 54
BR - Brasile 49
AT - Austria 34
BE - Belgio 16
CA - Canada 15
VN - Vietnam 14
ID - Indonesia 12
CZ - Repubblica Ceca 10
AE - Emirati Arabi Uniti 9
EU - Europa 8
JP - Giappone 5
NL - Olanda 5
CH - Svizzera 4
IQ - Iraq 3
MA - Marocco 3
AR - Argentina 2
BD - Bangladesh 2
CL - Cile 2
EC - Ecuador 2
ET - Etiopia 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
MX - Messico 2
PA - Panama 2
PH - Filippine 2
PL - Polonia 2
PT - Portogallo 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ES - Italia 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
PE - Perù 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 7.872
Salva come PNG Salva come JPEG
Città #
Dublin 934
Chandler 536
Jacksonville 428
Dearborn 325
Nyköping 291
Nanjing 205
Hong Kong 184
Singapore 132
Beijing 119
Santa Clara 114
Wilmington 102
Princeton 98
Ashburn 84
Nanchang 71
Ann Arbor 70
New York 66
San Mateo 63
Helsinki 51
Des Moines 49
Boardman 47
Shenyang 47
Hebei 44
Rome 41
Tianjin 39
Hilden 36
Woodbridge 33
Jiaxing 32
Foggia 30
Kunming 30
Pune 29
Hangzhou 28
Jinan 28
Guangzhou 26
Vienna 26
Los Angeles 25
Munich 23
Changsha 18
Ningbo 17
Brussels 16
Milan 15
Moscow 14
Wuhan 14
Zhengzhou 14
Dong Ket 12
Falls Church 12
San Severo 12
Bari 11
Shanghai 11
Lanzhou 10
Norwalk 10
Auburn Hills 9
Jakarta 9
Washington 9
Houston 8
Redwood City 8
Hefei 7
Santeramo In Colle 7
Council Bluffs 6
Falkenstein 6
Kocaeli 6
Naples 6
Orange 6
Seattle 6
Taizhou 6
Venice 6
Brno 5
Changchun 5
Fuzhou 5
New Delhi 5
Nuremberg 5
Perugia 5
Saarbrücken 5
São Paulo 5
Baltimore 4
Bologna 4
Caserta 4
Manfredonia 4
Paris 4
Philadelphia 4
Reno 4
Rockville 4
Tappahannock 4
Toronto 4
Cassino 3
Catania 3
Chongqing 3
Düsseldorf 3
Genova 3
Newark 3
Niedernberg 3
Palermo 3
Pavia 3
Pimonte 3
Rio de Janeiro 3
Saga 3
St Petersburg 3
Stockholm 3
Turin 3
Waterloo 3
Xinxiang 3
Totale 4.908
Salva come PNG Salva come JPEG
Nome #
Use of mammalian target of rapamycin inhibitor for treating pathologies including neurodegenerative diseases (Alzheimer's disease), neuroinflammatory diseases and tumor diseases with neurological involvement, by intrathecal administration 181
Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in wistar rats. 137
Social memory impairment in a triple-transgenic mouse model of Alzhemer's disease is accompained by monoaminergic alterations 126
The cannabinoid agonist WIN55212-2 normalizes levodopa-induced volume transmission unbalances across the two brain hemispheres of dyskinetic rats 119
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors 118
Data available on the extent of cocaine use and dependence: Biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. 115
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 114
Biochemical and Neurobehavioral Profile of CHF2819, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease 112
Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels 111
Mice lacking fatty acid amide hydrolase (FAAH-/-) showed increased serotonergic neurotransmission and reduced emotional reactivity 108
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 108
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex 106
Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration 106
Cannabinoids normalize neurochemical unbalances across the two hemispheres of dyskinetic rats 104
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 102
Antinutritional effects of fumonisin B1 and pathophysiological consequences 101
Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats 100
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion 99
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 98
Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor 97
Effects of early postnatal exposure to low concentrations of carbon monoxide on cognitive functions in rats 96
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles 94
5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease 94
Prenatal exposure to low concentrations of carbon monoxide alters habituation and non-spatial working memory in rat offspring 92
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 92
CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor 92
Cannabinoid receptor 2 signaling in neurodegenerative disorders: From pathogenesis to a promising therapeutic target 92
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 92
Aberrant insulin signaling in Alzheimer's disease: current knowledge 92
Effects of prenatal exposure to low concentrations of carbon monoxide on sexual behaviour and mesolimbic dopaminergic function in rat offspring 90
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 90
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 90
Striatal 6-Ohda Lesion In Mice: Investigating Early Neurochemical Changes Underlying Parkinson's Disease 89
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons 89
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function 88
Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder 86
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice 86
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs 85
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 84
Role of the area postrema in the hypophagic effects of oleoylethanolamide 84
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 84
Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects 84
Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC. 83
Novel codrugs with GABAergic activity for dopamine delivery in the brain 83
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease 82
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm 80
Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice 80
Prenatal Exposure to the CB1 Receptor Agonist Win 55,212-2 Causes Learning Disruption Associated With Impaired Cortical NMDA Receptor Function and Emotional Reactivity Changes in Rat Offspring 79
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress 79
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease. 78
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery 77
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 77
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 76
Olfactory memory is impaired in a triple transgenic model of Alzheimer disease 76
The effects of oleoylethanolamide on feeding behaviour involve hypothalamic oxytocin neurons 75
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures 75
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: An in vivo study 75
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 75
Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer’s Disease: In Vitro and In Vivo Evidence 71
Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats 70
Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [(13)C2D4]RAD001 internal standard 70
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin 69
Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide 69
Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease 69
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress 68
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 68
Astrocyte function is affected by aging and not Alzheimer's disease: A preliminary investigation in hippocampi of 3xTg-AD mice 67
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease 66
Delta9-Tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons. Involvement of CB1 receptors 65
Effects of ENA713 and CHF2819, two anti-Alzheimer’s disease drugs, on rat amino acid levels 65
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model 65
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 65
The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: An in vivo microdialysis study in the awake rat 65
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease 64
Insulin signaling: An opportunistic target to minify risk of Alzheimer's disease 64
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 64
Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge-eating disorder 64
Neurochemical changes produced by CHF2819, a novel, orally active acetylcholinesterase inhibitor, in rat brain 63
Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. 62
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 61
From obesity resistance to obesity prediction and prevention? 60
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 58
Editorial: Dysmetabolism, obesity, and inflammation: Three prominent actors in the drama of major neuropsychiatric disorders 57
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats 56
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease 56
Oxidative Stress in Aging Brain: Nutritional and Pharmacological Interventions for Neurodegenerative Disorders 56
TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells 55
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus 55
Compromised decision-making and increased gambling proneness following dietary serotonin depletion in rats 53
Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice 52
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 51
Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide 49
Lung histopathological findings in COVID-19 disease - a systematic review 47
Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients 47
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 47
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 44
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 41
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 40
The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in alzheimer’s disease 38
Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease 37
Totale 7.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.569
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020267 0 0 0 0 0 0 0 0 100 20 125 22
2020/2021860 114 8 102 68 110 70 112 13 115 131 1 16
2021/2022538 64 11 4 8 39 14 12 38 89 76 30 153
2022/20232.350 202 96 96 158 115 230 39 194 1.104 23 46 47
2023/2024472 61 32 17 23 46 157 21 11 2 11 2 89
2024/20251.204 85 19 79 64 72 234 231 95 325 0 0 0
Totale 8.282